“Sector & Segment works with a range of pharma & biopharma players, helping them improve their market positioning in relevant therapeutic areas, both through in-depth qualitative understandings of the medical landscape and quantitative analysis of their portfolio competitiveness”

We work with a variety of pharma & biopharma companies whose distinct go-to-market models each require unique insights and strategies. For example, it can be challenging for B2B pharma players, or those who have set up a network of local distribution partnerships, to influence patient journeys, communications with HCPs and patients, and ultimately product choice. We work closely with these types of players to ensure they transmit the right information to their partners and customers to drive more business.

Other challenges we tackle with our clients include:

• Stress testing planned product launches, or sizing the potential of product / innovation pipelines
• Expanding applications of our client’s solutions to adjacent or new therapeutic areas, whilst adapting to regulatory conditions for market access
• Supporting the adoption of solutions that target prevention of symptoms, diseases, or disease progression, which can be harder to build evidence for compared to curative solutions

Examples of Therapeutic Areas we have worked on:

• Autoimmune Diseases (Lupus, Primary Humoral Immunodeficiency, Rheumatoid Arthritis)
• Cancer (Breast, Lower/Upper GI, Head & Neck, Prostate, Lung, Uterine)
• COPD
• Cystic Fibrosis
• Diabetes Type 1/2
• Infectious Respiratory Diseases
• Inflammatory Bowel Diseases
• Muscular Dystrophy
• Pain Management
• Parkinson’s Disease
• Stroke